Completed PHASE1 INTERVENTIONAL 4-arm NCT02376608

Bioavailability of Omega-3 Food Supplement in Healthy Subjects

Pronovum - An Open-label, Randomized, Single-dose Study to Evaluate the Bioavailability of Omega-3 Food Supplements in Healthy Male and Female Subjects.

Sponsor: Pronova BioPharma

Conditions Biological Availability

Interventions Eskimo-3 Pronova Pure 150:500 EE EU Pronovum PRF-037 Pronovum PRF-041

Updated 5 times since 2017 Last updated: Feb 25, 2015 Started: Aug 31, 2014 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02376608, this PHASE1 trial focuses on Biological Availability and remains completed. Sponsored by Pronova BioPharma, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pronova BioPharma

Data source: Pronova BioPharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leeds, United Kingdom